Immunization News and Research

RSS
A new measles-based COVID-19 vaccine

A new measles-based COVID-19 vaccine

A biomaterial vaccine for SARS-CoV-2 - quick and scalable

A biomaterial vaccine for SARS-CoV-2 - quick and scalable

ACS publishes updated guideline for HPV vaccination

ACS publishes updated guideline for HPV vaccination

New technology can rapidly disrupt existing biofilms that account for chronic diseases

New technology can rapidly disrupt existing biofilms that account for chronic diseases

Research suggests protective effect of influenza vaccine against COVID-19 severity and mortality

Research suggests protective effect of influenza vaccine against COVID-19 severity and mortality

Novavax SARS-CoV-2 vaccine candidate shows promise in animal models

Novavax SARS-CoV-2 vaccine candidate shows promise in animal models

Coronavirus immunity is higher than previously thought, study finds

Coronavirus immunity is higher than previously thought, study finds

Important new findings on T cell immunity in COVID-19

Important new findings on T cell immunity in COVID-19

Hollowed-out public health system faces more cuts amid virus

Hollowed-out public health system faces more cuts amid virus

HPV vaccine policies may lead to higher vaccination rates, reduce cancer rates

HPV vaccine policies may lead to higher vaccination rates, reduce cancer rates

First clinical trial in South Africa for Covid-19 vaccine begins

First clinical trial in South Africa for Covid-19 vaccine begins

Single-dose Israeli vaccine candidate protective against SARS-CoV-2

Single-dose Israeli vaccine candidate protective against SARS-CoV-2

Reassuring news on the Oxford vaccine (AZD1222) against SARS-CoV-2

Reassuring news on the Oxford vaccine (AZD1222) against SARS-CoV-2

AFFiRiS AG announces results of phase 1 trial with PD01A in Parkinson's

AFFiRiS AG announces results of phase 1 trial with PD01A in Parkinson's

Novel SARS-CoV-2 antibody cocktail impeccably mimics human antibody response

Novel SARS-CoV-2 antibody cocktail impeccably mimics human antibody response

Tuberculosis and polio vaccines may offer temporary protection against SARS-CoV-2

Tuberculosis and polio vaccines may offer temporary protection against SARS-CoV-2

Females mount stronger T-cell response to SARS-CoV-2

Females mount stronger T-cell response to SARS-CoV-2

Scientists investigate immune responses to SARS-CoV-2 spike immunogens

Scientists investigate immune responses to SARS-CoV-2 spike immunogens

Convalescent plasma therapy for COVID-19 is safe and effective

Convalescent plasma therapy for COVID-19 is safe and effective

Census of viral spike protein antigens could benefit development of SARS-CoV-2 therapeutics

Census of viral spike protein antigens could benefit development of SARS-CoV-2 therapeutics